We noticed you’re blocking ads

Thanks for visiting MillennialEYE. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://millennialeye.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

The Buzz | Nov/Dec '19

The Buzz

TO LISTEN | This Podcast Will Kill You

Two graduate students studying disease ecology set out to “share their love of epidemics and weird medical mysteries with the world.” This Podcast Will Kill You covers a variety of topics—ranging from encephalitis lethargica, to hookworms, to scurvy—and inspires new levels of hand washing.

TO READ | The Cost of Resubmission

Most research manuscripts are not accepted for publication on first submission and often require multiple rounds of revisions. A recent study was conducted to assess the magnitude of the burden imposed by the resubmission process—and it’s high.

TO FOLLOW | Scout: In or Out?

Eyeglass retailer Warby Parker has launched its own line of contact lenses, called Scout. Direct-to-consumer models, such as that used by Hubble, have caused concern among the optometric community. We’ll see how this plays out.

TO WATCH | Endophthalmitis Risk

On Clinical Minute, Zeba A. Syed, MD, sits down with Neda Shamie, MD, to discuss a retrospective, cohort study of endophthalmitis rates after penetrating keratoplasty and endothelial keratoplasty and shares clinical outcomes with both procedures.

Advertisement - Issue Continues Below
Publication Ad Publication Ad
End of Advertisement - Issue Continues Below

NEXT IN THIS ISSUE